For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Conjuchem Biotechnologies Inc.

USPTO Granted Patents = 10

EPO Patents = 1

Forward Citations = 194

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Martin Robitaille (6 out of 14 patents)

Dominique Bridon (5 out of 13 patents)

Dominique P Bridon (5 out of 26 patents)

4. Peter G Milner (4 out of 41 patents)

5. Karen Thibaudeau (4 out of 13 patents)

6. Nissab Boudjellab (3 out of 6 patents)

7. Roger Leger (2 out of 11 patents)

8. Darren L Holmes (2 out of 16 patents)

9. Xicai Huang (2 out of 4 patents)

10. Wolin Huang (1 out of 26 patents)

11. Alexander Krantz (1 out of 27 patents)

12. Grant A Krafft (1 out of 9 patents)

13. Richard Beliveau (1 out of 10 patents)

14. John W Erickson (1 out of 20 patents)

15. Dong Xie (1 out of 5 patents)

10 patents: Sort by Forward Citations

1. 7741453 - Long lasting fusion peptide inhibitors for HIV infection (2010-06-22),

2. 7741286 - Long lasting anti-angiogenic peptides (2010-06-22),

3. 7737251 - Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders (2010-06-15),

4. 7608271 - Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group (2009-10-27),

5. 7601691 - Anti-obesity agents (2009-10-13),

6. 7582301 - Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides (2009-09-01),

7. 7307148 - Method for purification of albumin conjugates (2007-12-11),

8. 7268113 - Long lasting growth hormone releasing factor derivatives (2007-09-11),

9. 7256253 - Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components (2007-08-14),

10. 7166695 - Affinity markers for human serum albumin (2007-01-23),

ConjuChem Biotechnologies Inc. is a biopharmaceutical company that focuses on developing and commercializing new therapies for the treatment of chronic debilitating diseases. Our proprietary drug development platform allows us to create novel peptide-based therapeutics with improved efficacy and safety profiles. With a strong pipeline of promising drug candidates, we are committed to advancing the field of biotechnology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#92 in Montreal

#1,468 in Canada

#54,324 in the World

Montreal, Canada

Conjuchem Biotechnologies Inc.

Forward Citations = 194

30 inventors:

Martin Robitaille (6 out of 14 patents)

Dominique Bridon (5 out of 13 patents)

Dominique P Bridon (5 out of 26 patents)

4. Peter G Milner (4 out of 41 patents)

5. Karen Thibaudeau (4 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…